Clinical Trials in Austin

Showing 8941-8960 of 11,561 trials

HeartLight Ablation in Patients With Paroxysmal Atrial Fibrillation (PAF)

NCT01456000

The purpose of this study is to demonstrate the safety and effectiveness of the CardioFocus Endoscopic Ablation System with Adaptive Contact (HeartLight) in the treatment of atrial fibrillation by creating electrical isolation of the pulmonary veins.

Paroxysmal Atrial Fibrillation

CardioFocus405 participantsStarted Jan 2012

Birminham, Alabama, United States • Palo Alto, California, United States • Sacramento, California, United States +18 more locations

TERMINATEDPhase 2< 1 mile

Regorafenib Eye Drops: Investigation of Efficacy and Safety in Neovascular Age Related Macular Degeneration

NCT02222207

Part A (Phase IIa): Primary objectives: The study part A is designed to investigate whether the use of regorafenib eye drops can help patients with neovascular (wet) Age-Related Macular Degeneration (wAMD) to see better after 4 weeks and 12 weeks after inclusion into this study. Secondary objectives: The study will also evaluate the safety and tolerability of the regorafenib eye drops. Part B (Phase IIb): Primary objectives: The study part B is designed to investigate: * how often the regorafenib eye drops need to be given per day * whether the use of regorafenib eye drops can help patients with neovascular (wet) Age-Related Macular Degeneration (wAMD) to see better after 4 weeks and 12 weeks after inclusion into this study. Secondary objectives: The study will also evaluate how the different dosings of regorafenib eye drops affect patients vision, the safety and the tolerability.

Macular Degeneration

Bayer52 participantsStarted Oct 2014

Tucson, Arizona, United States • Arcadia, California, United States • Beverly Hills, California, United States +146 more locations

HeartLight Ablation in Patients With Paroxysmal Atrial Fibrillation (PAF)

Regorafenib Eye Drops: Investigation of Efficacy and Safety in Neovascular Age Related Macular Degeneration

Find Trials by Condition in Austin

Bipolar Study in Adults at Least 18 Years of Age

Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-Experienced Genotype 1 Hepatitis C Infected Patients (STARTverso 3)

A Combined Tdap Vaccine Used As A Booster Compared To Licensed Td Vaccine

Rosiglitazone In Subjects With Type 2 Diabetes Mellitus Who Are Inadequately Controlled On Insulin

Finding a Safe and Effective Dose of Linagliptin in Pediatric Patients With Type 2 Diabetes

Venous Thromboembolic Event (VTE) Prophylaxis in Medically Ill Patients

A Study Of GW685698X For The Treatment Of Perennial Allergic Rhinitis In Pediatrics

Safety and Efficacy of Mipomersen (ISIS 301012) As Add-on Therapy in High Risk Hypercholesterolemic Patients

Efficacy and Safety Study of ISIS 301012 (Mipomersen) as Add-on in Familial Hypercholesterolemic Patients With Coronary Artery Disease

Depression And Bipolar Disorder

A Study of Vemurafenib (RO5185426) in Participants With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 Mutation

Open Label, Phase I ZD6474 Head and Neck Cancer Study

Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex

Seasonal Allergic Rhinitis In Pediatric Subjects

Neoadjuvant Sunitinib With Paclitaxel/Carboplatin in Patients With Triple-Negative Breast Cancer

Pharmacokinetic Study of CYCLOSET ® 0.8 mg Tablets in Children and Adolescent Type 2 Diabetes Mellitus Subjects

Robotic-assisted Versus Laparoscopic Sigmoid Resection

Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism